Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET-Reference-Cited by-同舟云学术

Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET

Published:2013-10 Issue:7 Volume:40 Page:912-918
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Kim Sung Won,Hooker Jacob M.,Otto Nicola,Win Khaing,Muench Lisa,Shea Colleen,Carter Pauline,King Payton,Reid Alicia E.,Volkow Nora D.,Fowler Joanna S.

Funder

U. S. Department of Energy, Office of Biological and Environmental Research

NIH Intramural Program of the National Institute on Alcohol Abuse and Alcoholism

BNL Science Undergraduate Laboratory Internship Program

Deutscher Akademischer Austauschdienst (DAAD)

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference48 articles.

1. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania;Bowden;J Clin Psychiatry,2006

2. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study;Lehrman;Lancet,2005